Tumour microenvironment immune markers associated with pathologic response to neoadjuvant pembrolizumab in muscle-invasive bladder cancer (Pure-01 trial: an open label, single arm, Phase II study)
VIRCHOWS ARCHIV（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要